ติดตาม
Manuela Ceccarelli
Manuela Ceccarelli
ยืนยันอีเมลแล้วที่ unict.it
ชื่อ
อ้างโดย
อ้างโดย
ปี
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.
F Diurno, FG Numis, G Porta, F Cirillo, S Maddaluno, A Ragozzino, ...
European Review for Medical & Pharmacological Sciences 24 (7), 2020
4012020
Editorial–Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet
M Ceccarelli, M Berretta, EV Rullo, G Nunnari, B Cacopardo
European review for medical and pharmacological sciences 24 (5), 2781-2783, 2020
1952020
The role of the hospital environment in the healthcare-associated infections: a general review of the literature.
A Facciolà, GF Pellicano, G Visalli, IA Paolucci, E VENANZI RULLO, ...
European Review for Medical & Pharmacological Sciences 23 (3), 2019
1452019
Silent COVID-19: what your skin can reveal
C Guarneri, EV Rullo, P Pavone, M Berretta, M Ceccarelli, A Natale, ...
The Lancet Infectious Diseases 21 (1), 24-25, 2021
982021
Resveratrol in cancer patients: from bench to bedside
M Berretta, A Bignucolo, R Di Francia, F Comello, G Facchini, ...
International journal of molecular sciences 21 (8), 2945, 2020
922020
Multiple effects of ascorbic acid against chronic diseases: Updated evidence from preclinical and clinical studies
M Berretta, V Quagliariello, N Maurea, R Di Francia, S Sharifi, G Facchini, ...
Antioxidants 9 (12), 1182, 2020
902020
HIV‐associated psoriasis: epidemiology, pathogenesis, and management
M Ceccarelli, E Venanzi Rullo, M Vaccaro, A Facciolà, F d'Aleo, ...
Dermatologic Therapy 32 (2), e12806, 2019
832019
Congenital cytomegalovirus infection: current strategies and future perspectives.
D Buonsenso, D Serranti, L Gargiullo, M Ceccarelli, O Ranno, P Valentini
European Review for Medical & Pharmacological Sciences 16 (7), 2012
822012
Carbon nanotubes and central nervous system: Environmental risks, toxicological aspects and future perspectives
A Facciolà, G Visalli, S La Maestra, M Ceccarelli, F D’Aleo, G Nunnari, ...
Environmental Toxicology and Pharmacology 65, 23-30, 2019
692019
Kaposi’s sarcoma in HIV-infected patients in the era of new antiretrovirals
A Facciolà, E Venanzi Rullo, M Ceccarelli, F D'aleo, M Di Rosa, ...
Eur Rev Med Pharmacol Sci 21 (24), 5868-5869, 2017
652017
Outbreak of COVID-19 infection in children: fear and serenity
P Pavone, M Ceccarelli, R Taibi, G La Rocca, G Nunnari
Eur Rev Med Pharmacol Sci 24 (8), 4572-4575, 2020
642020
Transmission mode associated with coronavirus disease 2019: a review.
F Vella, P Senia, M Ceccarelli, E Vitale, H Maltezou, R Taibi, A Lleshi, ...
European Review for Medical & Pharmacological Sciences 24 (14), 2020
602020
Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy
P Valentini, D Buonsenso, G Barone, D Serranti, R Calzedda, ...
Journal of Perinatology 35 (2), 90-94, 2015
602015
Diversity of clinical appearance of cutaneous manifestations in the course of COVID‐19
C Guarneri, EV Rullo, R Gallizzi, M Ceccarelli, SP Cannavò, G Nunnari
Journal of the European Academy of Dermatology and Venereology 34 (9), e449, 2020
572020
Persistence of an intact HIV reservoir in phenotypically naive T cells
EV Rullo, MR Pinzone, LM Cannon, S Weissman, M Ceccarelli, ...
JCI insight 5 (20), 2020
522020
SARS-CoV-2 related paediatric acute-onset neuropsychiatric syndrome
P Pavone, M Ceccarelli, S Marino, D Caruso, R Falsaperla, M Berretta, ...
The Lancet. Child & Adolescent Health 5 (6), e19, 2021
472021
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children
M Sali, D Buonsenso, P D'Alfonso, F De Maio, M Ceccarelli, B Battah, ...
Journal of Infection 77 (6), 526-533, 2018
452018
Malignant melanoma in HIV: Epidemiology, pathogenesis, and management
A Facciolà, E Venanzi Rullo, M Ceccarelli, F D'Andrea, M Coco, C Micali, ...
Dermatologic Therapy 33 (1), e13180, 2020
422020
Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors
EV Rullo, M Ceccarelli, F Condorelli, A Facciolà, G Visalli, F D'Aleo, ...
Molecular Medicine Reports 19 (3), 1987-1995, 2019
422019
Genetic evidence that naive T cells can contribute significantly to the human immunodeficiency virus intact reservoir: time to re-evaluate their role
E Venanzi Rullo, LM Cannon, MR Pinzone, M Ceccarelli, G Nunnari, ...
Clinical Infectious Diseases 69 (12), 2236-2237, 2019
412019
ระบบไม่สามารถดำเนินการได้ในขณะนี้ โปรดลองใหม่อีกครั้งในภายหลัง
บทความ 1–20